Sangio90TM vs Jin | 29–32 | 47.54% |
Sangio90TM vs Law | 30–24 | 55.56% |
Sangio90TM vs King | 21–20 | 51.22% |
Sangio90TM vs Kazuya | 18–19 | 48.65% |
Sangio90TM vs Paul | 19–11 | 63.33% |
Sangio90TM vs Hwoarang | 16–14 | 53.33% |
Sangio90TM vs Lili | 6–23 | 20.69% |
Sangio90TM vs Reina | 16–11 | 59.26% |
Sangio90TM vs Yoshimitsu | 13–12–1 | 52.00% |
Sangio90TM vs Lee | 13–12 | 52.00% |
Sangio90TM vs Xiaoyu | 14–10 | 58.33% |
Sangio90TM vs Bryan | 12–12 | 50.00% |
Sangio90TM vs Steve | 15–8 | 65.22% |
Sangio90TM vs Dragunov | 9–11 | 45.00% |
Sangio90TM vs Feng | 6–10 | 37.50% |
Sangio90TM vs Azucena | 11–5 | 68.75% |
Sangio90TM vs Nina | 8–6 | 57.14% |
Sangio90TM vs Jun | 10–3 | 76.92% |
Sangio90TM vs Heihachi | 9–4 | 69.23% |
Sangio90TM vs Lidia | 9–2 | 81.82% |
Sangio90TM vs Asuka | 7–3 | 70.00% |
Sangio90TM vs Lars | 1–8 | 11.11% |
Sangio90TM vs Alisa | 3–5 | 37.50% |
Sangio90TM vs Kuma | 3–5 | 37.50% |
Sangio90TM vs Eddy | 2–6 | 25.00% |
Sangio90TM vs Devil Jin | 1–6 | 14.29% |
Sangio90TM vs Leo | 5–2 | 71.43% |
Sangio90TM vs Claudio | 3–4 | 42.86% |
Sangio90TM vs Victor | 4–3 | 57.14% |
Sangio90TM vs Leroy | 5–1 | 83.33% |
Sangio90TM vs Raven | 2–3 | 40.00% |
Sangio90TM vs Jack-8 | 3–1 | 75.00% |
Sangio90TM vs Zafina | 1–3 | 25.00% |
Sangio90TM vs Shaheen | 2–1 | 66.67% |
Sangio90TM vs Clive | 0–2 | 0.00% |
Sangio90TM vs Panda | 0–1 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.